Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Merck & Co., Inc.MRK · Entity 2807 | Director | May 29, 2026 | June 02, 2026 |
| NORTHROP GRUMMAN CORP /DE/NOC · Entity 2963 | Director · Chair, CEO and President | August 19, 2026 | August 21, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Merck & Co., Inc.
Report date May 29, 2026 · Filed June 02, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Phantom StockSEC Table II · derivative / convertible security | Direct | 17,890.2917 |
Reported balance
After 2026-05-29 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2026-05-29 · Grant · Acquired 1,853.0997 · Balance 17,890.2917 F1: 1-for-1 F2: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F3: Holdings include shares acquired in dividend reinvestment transactions. |
| Common StockSEC Table I · non-derivative | Direct | 500 |
Reported balance
Holding disclosure · report date 2026-05-29 · row 1
Holding and transaction disclosures are not merged.
1 source rowRow 1 · Balance 500 |
Filing footnotes · ownership attribution and instrument terms
F1: 1-for-1
F2: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation.
F3: Holdings include shares acquired in dividend reinvestment transactions.
NORTHROP GRUMMAN CORP /DE/
Report date August 19, 2026 · Filed August 21, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Market Stock UnitsSEC Table II · derivative / convertible security | Direct | 35,910 |
Reported balance
After 2026-08-19 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-08-19 · Grant · Acquired 35,910 · Balance 35,910 F1: Each Market Stock Unit ("MSU") represents the contingent right to receive, following vesting, between 0% and 150% of one share of the Issuer's common stock, subject to the Issuer's absolute stock price appreciation or depreciation over a performance period ending December 31, 2031. No portion of the MSUs will be earned if the Issuer's stock price depreciates by more than 25%, a 100% (or target) payout is earned if the Issuer's stock price appreciates by 10%, and a 150% payout is earned if the Issuer's stock price appreciates by 50% or more. The target number of MSUs is reported in this Report. Grant awarded pursuant to Rule 16b-3(d). |
Filing footnotes · ownership attribution and instrument terms
F1: Each Market Stock Unit ("MSU") represents the contingent right to receive, following vesting, between 0% and 150% of one share of the Issuer's common stock, subject to the Issuer's absolute stock price appreciation or depreciation over a performance period ending December 31, 2031. No portion of the MSUs will be earned if the Issuer's stock price depreciates by more than 25%, a 100% (or target) payout is earned if the Issuer's stock price appreciates by 10%, and a 150% payout is earned if the Issuer's stock price appreciates by 50% or more. The target number of MSUs is reported in this Report. Grant awarded pursuant to Rule 16b-3(d).
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 19, 2026 Filed Aug 21, 2026 21:10 UTC | NORTHROP GRUMMAN CORP /DE/ NOC · Entity 2963 | GrantMarket Stock Units · Derivative | 35,910 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-26-058482 · wk-form4_1787346622.xml · derivative · entry 1 Warden Kathy J · CIK 0001559112 · Director · Chair, CEO and President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 35,910 Underlying: Common Stock · 35,910 shares Expires not disclosed F1 · derivative.exercise_price: Each Market Stock Unit ("MSU") represents the contingent right to receive, following vesting, between 0% and 150% of one share of the Issuer's common stock, subject to the Issuer's absolute stock price appreciation or depreciation over a performance period ending December 31, 2031. No portion of the MSUs will be earned if the Issuer's stock price depreciates by more than 25%, a 100% (or target) payout is earned if the Issuer's stock price appreciates by 10%, and a 150% payout is earned if the Issuer's stock price appreciates by 50% or more. The target number of MSUs is reported in this Report. Grant awarded pursuant to Rule 16b-3(d). F1 · derivative.exercise_date: Each Market Stock Unit ("MSU") represents the contingent right to receive, following vesting, between 0% and 150% of one share of the Issuer's common stock, subject to the Issuer's absolute stock price appreciation or depreciation over a performance period ending December 31, 2031. No portion of the MSUs will be earned if the Issuer's stock price depreciates by more than 25%, a 100% (or target) payout is earned if the Issuer's stock price appreciates by 10%, and a 150% payout is earned if the Issuer's stock price appreciates by 50% or more. The target number of MSUs is reported in this Report. Grant awarded pursuant to Rule 16b-3(d). F1 · derivative.expiration_date: Each Market Stock Unit ("MSU") represents the contingent right to receive, following vesting, between 0% and 150% of one share of the Issuer's common stock, subject to the Issuer's absolute stock price appreciation or depreciation over a performance period ending December 31, 2031. No portion of the MSUs will be earned if the Issuer's stock price depreciates by more than 25%, a 100% (or target) payout is earned if the Issuer's stock price appreciates by 10%, and a 150% payout is earned if the Issuer's stock price appreciates by 50% or more. The target number of MSUs is reported in this Report. Grant awarded pursuant to Rule 16b-3(d). Read SEC document |
| May 29, 2026 Filed Jun 2, 2026 20:14 UTC | Merck & Co., Inc. MRK · Entity 2807 | GrantPhantom Stock · Derivative | 1,853.0997 | $118.72 | $220,000.00 |
DisclosureSEC source: 0000310158-26-000177 · form4.xml · derivative · entry 2 Warden Kathy J · CIK 0001559112 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,890.2917 Underlying: Common Stock · 1,853.0997 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F2 · derivative.exercise_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F2 · derivative.expiration_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F3 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| February 17, 2026 Filed Feb 19, 2026 21:25 UTC | NORTHROP GRUMMAN CORP /DE/ NOC · Entity 2963 | Exercise / conversionRestricted Stock Rights · Derivative | 10,760 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-26-009786 · wk-form4_1771536318.xml · derivative · entry 3 Warden Kathy J · CIK 0001559112 · Director · Chair, CEO and President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 31,020 Underlying: Common Stock · 10,760 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Right ("RSR") represents a contingent right to receive an equivalent number of shares in Issuer common stock, or, at the election of the Issuer's Compensation Committee, cash or a combination of cash and Issuer common stock. F1 · derivative.exercise_date: Each Restricted Stock Right ("RSR") represents a contingent right to receive an equivalent number of shares in Issuer common stock, or, at the election of the Issuer's Compensation Committee, cash or a combination of cash and Issuer common stock. F2 · derivative.expiration_date: Shares issued upon vesting of RSRs granted under the 2011 Long-Term Incentive Stock Plan ("2011 LTISP") on 2/16/23 that vested on 2/17/26. F3 · balance_after: Total amount includes (i) 11,155 RSRs granted under the 2011 LTISP on 2/14/24 that will vest on 2/16/27; (ii) 11,752 RSRs granted under the 2024 LTISP on 2/18/25 that will vest on 2/18/28; and (iii) 8,113 RSRs granted under 2024 LTISP on 2/11/26 that will vest on 2/12/29. Read SEC document |
| February 17, 2026 Filed Feb 19, 2026 21:25 UTC | NORTHROP GRUMMAN CORP /DE/ NOC · Entity 2963 | Tax withholdingCommon Stock | 4,857 | $701.12 | $3,405,339.84 |
DisclosureSEC source: 0001628280-26-009786 · wk-form4_1771536318.xml · nonDerivative · entry 2 Warden Kathy J · CIK 0001559112 · Director · Chair, CEO and President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 196,680.56 Read SEC document |
| February 17, 2026 Filed Feb 19, 2026 21:25 UTC | NORTHROP GRUMMAN CORP /DE/ NOC · Entity 2963 | Exercise / conversionCommon Stock | 10,760 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-26-009786 · wk-form4_1771536318.xml · nonDerivative · entry 1 Warden Kathy J · CIK 0001559112 · Director · Chair, CEO and President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 201,537.56 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 11, 2026 Filed Feb 13, 2026 21:16 UTC | NORTHROP GRUMMAN CORP /DE/ NOC · Entity 2963 | Exercise / conversionRestricted Performance Stock Rights · Derivative | 34,546.16 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-26-008125 · wk-form4_1771017390.xml · derivative · entry 5 Warden Kathy J · CIK 0001559112 · Director · Chair, CEO and President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 67,518 Underlying: Common Stock · 34,546.16 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Performance Stock Right ("RPSR") represents a contingent right to receive an equivalent number of shares of Issuer common stock, or, at the Issuer's election, cash or a combination of cash and Issuer common stock. The RPSRs vest if the applicable performance metric is satisfied for the relevant measurement period. Grants awarded pursuant to Rule 16b-3(d). F1 · derivative.exercise_date: Each Restricted Performance Stock Right ("RPSR") represents a contingent right to receive an equivalent number of shares of Issuer common stock, or, at the Issuer's election, cash or a combination of cash and Issuer common stock. The RPSRs vest if the applicable performance metric is satisfied for the relevant measurement period. Grants awarded pursuant to Rule 16b-3(d). F1 · derivative.expiration_date: Each Restricted Performance Stock Right ("RPSR") represents a contingent right to receive an equivalent number of shares of Issuer common stock, or, at the Issuer's election, cash or a combination of cash and Issuer common stock. The RPSRs vest if the applicable performance metric is satisfied for the relevant measurement period. Grants awarded pursuant to Rule 16b-3(d). F7 · balance_after: Total amount includes (i) 24,309 RPSRs granted under the 2011 LTISP on 2/16/24 with a measurement period ending on 12/31/26; (ii) 25,628 RPSRs granted under the 2024 LTISP on 2/18/25 with a measurement period ending on 12/31/27; and (iii) 17,581 RPSRs granted under the 2024 LTISP on 2/11/26 with a measurement period ending 12/31/28. Read SEC document |
| February 11, 2026 Filed Feb 13, 2026 21:16 UTC | NORTHROP GRUMMAN CORP /DE/ NOC · Entity 2963 | GrantRestricted Stock Rights · Derivative | 8,113 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-26-008125 · wk-form4_1771017390.xml · derivative · entry 4 Warden Kathy J · CIK 0001559112 · Director · Chair, CEO and President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 41,780 Underlying: Common Stock · 8,113 shares Expires not disclosed F4 · derivative.exercise_price: Each Restricted Stock Right ("RSR") represents a contingent right to receive an equivalent number of shares in Issuer common stock, or, at the election of the Issuer's Compensation Committee, cash or a combination of cash and Issuer common stock. F4 · derivative.exercise_date: Each Restricted Stock Right ("RSR") represents a contingent right to receive an equivalent number of shares in Issuer common stock, or, at the election of the Issuer's Compensation Committee, cash or a combination of cash and Issuer common stock. F5 · derivative.expiration_date: The RSRs were granted under the 2024 LTISP on 2/11/26 and will vest on 2/12/29. F6 · balance_after: Total amount includes (i) 10,760 RSRs granted under the 2011 LTISP on 2/16/23 that will vest on 2/17/26; (ii) 11,155 RSRs granted under the 2011 LTISP on 2/14/24 that will vest on 2/16/27; (iii) 11,752 RSRs granted under the 2024 LTISP on 2/18/25 that will vest on 2/18/28; and (iv) 8,113 RSRs granted under 2024 LTISP on 2/11/26 that will vest on 2/12/29. Read SEC document |
| February 11, 2026 Filed Feb 13, 2026 21:16 UTC | NORTHROP GRUMMAN CORP /DE/ NOC · Entity 2963 | GrantRestricted Performance Stock Rights · Derivative | 28,785.16 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-26-008125 · wk-form4_1771017390.xml · derivative · entry 3 Warden Kathy J · CIK 0001559112 · Director · Chair, CEO and President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 102,064.16 Underlying: Common Stock · 28,785.16 shares Expires not disclosed F1 · derivative.exercise_price: Each Restricted Performance Stock Right ("RPSR") represents a contingent right to receive an equivalent number of shares of Issuer common stock, or, at the Issuer's election, cash or a combination of cash and Issuer common stock. The RPSRs vest if the applicable performance metric is satisfied for the relevant measurement period. Grants awarded pursuant to Rule 16b-3(d). F2 · shares: The RPSRs acquired include (i) 11,204.16 vested RPSRs with respect to the measurement period ended 12/31/25 acquired due to settlement of the RPSRs granted under the 2011 Long-Term Incentive Stock Plan ("2011 LTISP") on 2/16/23 that resulted in settlement at 148% of the target award; and (ii) 17,581 unvested RPSRs granted under the 2024 Long-Term Incentive Stock Plan (the "2024 LTISP") on 2/11/26 with a measurement period ending on 12/31/28. A total of 34,546.16 shares were issued in settlement of the 2023 RPSRs with a measurement period that ended 12/31/25, and the target award amount of 23,342 RPSRs was previously reported in connection with the grant of the 2023 RPSRs. F1 · derivative.exercise_date: Each Restricted Performance Stock Right ("RPSR") represents a contingent right to receive an equivalent number of shares of Issuer common stock, or, at the Issuer's election, cash or a combination of cash and Issuer common stock. The RPSRs vest if the applicable performance metric is satisfied for the relevant measurement period. Grants awarded pursuant to Rule 16b-3(d). F1 · derivative.expiration_date: Each Restricted Performance Stock Right ("RPSR") represents a contingent right to receive an equivalent number of shares of Issuer common stock, or, at the Issuer's election, cash or a combination of cash and Issuer common stock. The RPSRs vest if the applicable performance metric is satisfied for the relevant measurement period. Grants awarded pursuant to Rule 16b-3(d). F3 · balance_after: Total amount includes (i) 34,546.16 vested RPSRs granted under the 2011 LTISP on 2/16/23 with a measurement period ended on 12/31/25; (ii) 24,309 RPSRs granted under the 2011 LTISP on 2/14/24 with a measurement period ending on 12/31/26; (iii) 25,628 RPSRs granted under the 2024 LTISP on 2/18/25 with a measurement period ending on 12/31/27; and (iv) 17,581 RPSRs granted under the 2024 LTISP on 2/11/26 with a measurement period ending on 12/31/28. Read SEC document |
| February 11, 2026 Filed Feb 13, 2026 21:16 UTC | NORTHROP GRUMMAN CORP /DE/ NOC · Entity 2963 | Tax withholdingCommon Stock | 15,371 | $678.83 | $10,434,295.93 |
DisclosureSEC source: 0001628280-26-008125 · wk-form4_1771017390.xml · nonDerivative · entry 2 Warden Kathy J · CIK 0001559112 · Director · Chair, CEO and President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 190,777.56 Read SEC document |
| February 11, 2026 Filed Feb 13, 2026 21:16 UTC | NORTHROP GRUMMAN CORP /DE/ NOC · Entity 2963 | Exercise / conversionCommon Stock | 34,546.16 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-26-008125 · wk-form4_1771017390.xml · nonDerivative · entry 1 Warden Kathy J · CIK 0001559112 · Director · Chair, CEO and President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 206,148.56 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 06, 2026 Filed Feb 10, 2026 21:04 UTC | NORTHROP GRUMMAN CORP /DE/ NOC · Entity 2963 | SaleCommon Stock | 1,306 | $711.14 | $928,748.84 |
DisclosureSEC source: 0001628280-26-006816 · wk-form4_1770757487.xml · nonDerivative · entry 7 Warden Kathy J · CIK 0001559112 · Director · Chair, CEO and President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 171,602.4 F7 · price: Represents the weighted average sale price of $711.14 rounded to the nearest hundredth. The highest price at which the shares were sold was $711.40 and the lowest price at which the shares were sold was $711.02. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote in this Form 4. Read SEC document |
| February 06, 2026 Filed Feb 10, 2026 21:04 UTC | NORTHROP GRUMMAN CORP /DE/ NOC · Entity 2963 | SaleCommon Stock | 3,552 | $710.36 | $2,523,198.72 |
DisclosureSEC source: 0001628280-26-006816 · wk-form4_1770757487.xml · nonDerivative · entry 6 Warden Kathy J · CIK 0001559112 · Director · Chair, CEO and President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 172,908.4 F6 · price: Represents the weighted average sale price of $710.36 rounded to the nearest hundredth. The highest price at which the shares were sold was $710.97 and the lowest price at which the shares were sold was $710.00. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote in this Form 4. Read SEC document |
| February 06, 2026 Filed Feb 10, 2026 21:04 UTC | NORTHROP GRUMMAN CORP /DE/ NOC · Entity 2963 | SaleCommon Stock | 5,734 | $709.49 | $4,068,215.66 |
DisclosureSEC source: 0001628280-26-006816 · wk-form4_1770757487.xml · nonDerivative · entry 5 Warden Kathy J · CIK 0001559112 · Director · Chair, CEO and President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 176,460.4 F5 · price: Represents the weighted average sale price of $709.49 rounded to the nearest hundredth. The highest price at which the shares were sold was $709.99 and the lowest price at which the shares were sold was $709.01. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote in this Form 4. Read SEC document |
| February 06, 2026 Filed Feb 10, 2026 21:04 UTC | NORTHROP GRUMMAN CORP /DE/ NOC · Entity 2963 | SaleCommon Stock | 2,303 | $708.63 | $1,631,974.89 |
DisclosureSEC source: 0001628280-26-006816 · wk-form4_1770757487.xml · nonDerivative · entry 4 Warden Kathy J · CIK 0001559112 · Director · Chair, CEO and President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 182,194.4 F4 · price: Represents the weighted average sale price of $708.63 rounded to the nearest hundredth. The highest price at which the shares were sold was $708.98 and the lowest price at which the shares were sold was $708.20. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote in this Form 4. Read SEC document |
| February 06, 2026 Filed Feb 10, 2026 21:04 UTC | NORTHROP GRUMMAN CORP /DE/ NOC · Entity 2963 | SaleCommon Stock | 4,695 | $707.45 | $3,321,477.75 |
DisclosureSEC source: 0001628280-26-006816 · wk-form4_1770757487.xml · nonDerivative · entry 3 Warden Kathy J · CIK 0001559112 · Director · Chair, CEO and President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 184,497.4 F3 · price: Represents the weighted average sale price of $707.45 rounded to the nearest hundredth. The highest price at which the shares were sold was $707.97 and the lowest price at which the shares were sold was $707.00. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote in this Form 4. Read SEC document |
| February 06, 2026 Filed Feb 10, 2026 21:04 UTC | NORTHROP GRUMMAN CORP /DE/ NOC · Entity 2963 | SaleCommon Stock | 2,196 | $706.65 | $1,551,803.40 |
DisclosureSEC source: 0001628280-26-006816 · wk-form4_1770757487.xml · nonDerivative · entry 2 Warden Kathy J · CIK 0001559112 · Director · Chair, CEO and President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 189,192.4 F2 · price: Represents the weighted average sale price of $706.65 rounded to the nearest hundredth. The highest price at which the shares were sold was $706.93 and the lowest price at which the shares were sold was $706.00. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote in this Form 4. Read SEC document |
| February 06, 2026 Filed Feb 10, 2026 21:04 UTC | NORTHROP GRUMMAN CORP /DE/ NOC · Entity 2963 | SaleCommon Stock | 214 | $705.84 | $151,049.76 |
DisclosureSEC source: 0001628280-26-006816 · wk-form4_1770757487.xml · nonDerivative · entry 1 Warden Kathy J · CIK 0001559112 · Director · Chair, CEO and President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 191,388.4 F1 · price: Represents the weighted average sale price of $705.84 rounded to the nearest hundredth. The highest price at which the shares were sold was $705.97 and the lowest price at which the shares were sold was $705.56. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote in this Form 4. Read SEC document |
| January 06, 2026 Filed Jan 7, 2026 21:35 UTC | NORTHROP GRUMMAN CORP /DE/ NOC · Entity 2963 | SaleCommon Stock | 3,000 | $615.00 | $1,845,000.00 |
DisclosureSEC source: 0001628280-26-001192 · wk-form4_1767821708.xml · nonDerivative · entry 2 Warden Kathy J · CIK 0001559112 · Director · Chair, CEO and President 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 191,602.4 F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 2, 2025. Read SEC document |
| January 05, 2026 Filed Jan 7, 2026 21:35 UTC | NORTHROP GRUMMAN CORP /DE/ NOC · Entity 2963 | SaleCommon Stock | 7,000 | $600.00 | $4,200,000.00 |
DisclosureSEC source: 0001628280-26-001192 · wk-form4_1767821708.xml · nonDerivative · entry 1 Warden Kathy J · CIK 0001559112 · Director · Chair, CEO and President 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 194,602.4 F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 2, 2025. Read SEC document |
| June 13, 2025 Filed Jun 13, 2025 21:14 UTC | NORTHROP GRUMMAN CORP /DE/ NOC · Entity 2963 | SaleCommon Stock | 7,500 | $505.77 | $3,793,275.00 |
DisclosureSEC source: 0001628280-25-031375 · wk-form4_1749849268.xml · nonDerivative · entry 2 Warden Kathy J · CIK 0001559112 · Director · Chair, CEO and President 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 201,602.4 F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 6, 2025. Read SEC document |
| June 12, 2025 Filed Jun 13, 2025 21:14 UTC | NORTHROP GRUMMAN CORP /DE/ NOC · Entity 2963 | SaleCommon Stock | 3,750 | $495.00 | $1,856,250.00 |
DisclosureSEC source: 0001628280-25-031375 · wk-form4_1749849268.xml · nonDerivative · entry 1 Warden Kathy J · CIK 0001559112 · Director · Chair, CEO and President 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 209,102.4 F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 6, 2025. Read SEC document |
| May 30, 2025 Filed Jun 3, 2025 17:45 UTC | Merck & Co., Inc. MRK · Entity 2807 | GrantPhantom Stock · Derivative | 2,863.0921 | $76.84 | $220,000.00 |
DisclosureSEC source: 0001127602-25-016390 · form4.xml · derivative · entry 2 Warden Kathy J · CIK 0001559112 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,503.599 Underlying: Common Stock · 2,863.0921 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F2 · derivative.exercise_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F2 · derivative.expiration_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F3 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| March 06, 2025 Filed Mar 6, 2025 23:19 UTC | NORTHROP GRUMMAN CORP /DE/ NOC · Entity 2963 | SaleCommon Stock | 3,750 | $475.65 | $1,783,687.50 |
DisclosureSEC source: 0001628280-25-011084 · wk-form4_1741303154.xml · nonDerivative · entry 1 Warden Kathy J · CIK 0001559112 · Director · Chair, CEO and President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 212,852.4 Read SEC document |
| February 18, 2025 Filed Feb 20, 2025 22:19 UTC | NORTHROP GRUMMAN CORP /DE/ NOC · Entity 2963 | Exercise / conversionRestricted Stock Rights · Derivative | 11,672 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-25-006867 · wk-form4_1740089980.xml · derivative · entry 8 Warden Kathy J · CIK 0001559112 · Director · Chair, CEO and President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 33,667 Underlying: Common Stock · 11,672 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each Restricted Stock Right ("RSR") represents a contingent right to receive an equivalent number of shares in Issuer common stock, or, at the election of the Issuer's Compensation Committee, cash or a combination of cash and Issuer common stock. F4 · derivative.exercise_date: Each Restricted Stock Right ("RSR") represents a contingent right to receive an equivalent number of shares in Issuer common stock, or, at the election of the Issuer's Compensation Committee, cash or a combination of cash and Issuer common stock. F8 · derivative.expiration_date: Shares issued upon vesting of RSRs granted under the 2011 LTISP on 2/15/22 that vested on 2/18/25. Read SEC document |
| February 18, 2025 Filed Feb 20, 2025 22:19 UTC | NORTHROP GRUMMAN CORP /DE/ NOC · Entity 2963 | Exercise / conversionRestricted Performance Stock Rights · Derivative | 27,350.27 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-25-006867 · wk-form4_1740089980.xml · derivative · entry 7 Warden Kathy J · CIK 0001559112 · Director · Chair, CEO and President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 73,279 Underlying: Common Stock · 27,350.27 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Performance Stock Right ("RPSR") represents a contingent right to receive an equivalent number of shares of Issuer common stock, or, at the Issuer's election, cash or a combination of cash and Issuer common stock. The RPSRs vest if the applicable performance metric is satisfied for the relevant measurement period. Grants awarded pursuant to Rule 16b-3(d). F1 · derivative.exercise_date: Each Restricted Performance Stock Right ("RPSR") represents a contingent right to receive an equivalent number of shares of Issuer common stock, or, at the Issuer's election, cash or a combination of cash and Issuer common stock. The RPSRs vest if the applicable performance metric is satisfied for the relevant measurement period. Grants awarded pursuant to Rule 16b-3(d). F1 · derivative.expiration_date: Each Restricted Performance Stock Right ("RPSR") represents a contingent right to receive an equivalent number of shares of Issuer common stock, or, at the Issuer's election, cash or a combination of cash and Issuer common stock. The RPSRs vest if the applicable performance metric is satisfied for the relevant measurement period. Grants awarded pursuant to Rule 16b-3(d). F7 · balance_after: Total amount includes (i) 23,342 RPSRs granted under the 2011 LTISP on 2/16/23 with a measurement period ending on 12/31/25; (ii) 24,309 RPSRs granted under the 2011 LTISP on 2/14/24 with a measurement period ending on 12/31/26; and (iii) 25,628 RPSRs granted under the 2024 LITSP on 2/18/25 with a measurement period ending on 12/31/27. Read SEC document |
| February 18, 2025 Filed Feb 20, 2025 22:19 UTC | NORTHROP GRUMMAN CORP /DE/ NOC · Entity 2963 | GrantRestricted Stock Rights · Derivative | 11,752 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-25-006867 · wk-form4_1740089980.xml · derivative · entry 6 Warden Kathy J · CIK 0001559112 · Director · Chair, CEO and President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 45,339 Underlying: Common Stock · 11,752 shares Expires not disclosed F4 · derivative.exercise_price: Each Restricted Stock Right ("RSR") represents a contingent right to receive an equivalent number of shares in Issuer common stock, or, at the election of the Issuer's Compensation Committee, cash or a combination of cash and Issuer common stock. F4 · derivative.exercise_date: Each Restricted Stock Right ("RSR") represents a contingent right to receive an equivalent number of shares in Issuer common stock, or, at the election of the Issuer's Compensation Committee, cash or a combination of cash and Issuer common stock. F5 · derivative.expiration_date: The RSRs were granted under the 2024 LTISP on 2/18/2025 and will vest on 2/18/2028. F6 · balance_after: Total amount includes (i) 11,672 RSRs granted under the 2011 LTISP on 2/15/22 that vested on 2/18/25; (ii) 10,760 RSRs granted under the 2011 LTISP on 2/16/23 that will vest on 2/17/26; (iii) 11,155 RSRs granted under the 2011 LTISP on 2/14/24 that will vest on 2/16/27; and (iv) 11,752 RSRs granted under 2024 LTISP on 2/18/25 that will vest on 2/18/28. Read SEC document |
| February 18, 2025 Filed Feb 20, 2025 22:19 UTC | NORTHROP GRUMMAN CORP /DE/ NOC · Entity 2963 | GrantRestricted Performance Stock Rights · Derivative | 27,417.27 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-25-006867 · wk-form4_1740089980.xml · derivative · entry 5 Warden Kathy J · CIK 0001559112 · Director · Chair, CEO and President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 100,629.27 Underlying: Common Stock · 27,417.27 shares Expires not disclosed F1 · derivative.exercise_price: Each Restricted Performance Stock Right ("RPSR") represents a contingent right to receive an equivalent number of shares of Issuer common stock, or, at the Issuer's election, cash or a combination of cash and Issuer common stock. The RPSRs vest if the applicable performance metric is satisfied for the relevant measurement period. Grants awarded pursuant to Rule 16b-3(d). F2 · shares: The RPSRs acquired include (i) 1,789.27 vested RPSRs with respect to the measurement period ended 12/31/24 acquired due to settlement of the RPSRs granted under the 2011 Long-Term Incentive Stock Plan ("2011 LTISP") on 2/15/22 that resulted in settlement at 107% of the target award; and (ii) 25,628 unvested RPSRs granted under the 2024 Long-Term Incentive Stock Plan (the "2024 LTISP") on 2/18/25 with a measurement period ending on 12/31/27. A total of 27,350.27 shares were issued in settlement of the 2022 RPSRs with a measurement period that ended 12/31/24, and the target award amount of 25,561 RPSRs was previously reported in connection with the grant of the 2022 RPSRs. F1 · derivative.exercise_date: Each Restricted Performance Stock Right ("RPSR") represents a contingent right to receive an equivalent number of shares of Issuer common stock, or, at the Issuer's election, cash or a combination of cash and Issuer common stock. The RPSRs vest if the applicable performance metric is satisfied for the relevant measurement period. Grants awarded pursuant to Rule 16b-3(d). F1 · derivative.expiration_date: Each Restricted Performance Stock Right ("RPSR") represents a contingent right to receive an equivalent number of shares of Issuer common stock, or, at the Issuer's election, cash or a combination of cash and Issuer common stock. The RPSRs vest if the applicable performance metric is satisfied for the relevant measurement period. Grants awarded pursuant to Rule 16b-3(d). F3 · balance_after: Total amount includes (i) 27,350.27 vested RPSRs granted under the 2011 LTISP on 2/15/22 with a measurement period ended on 12/31/24; (ii) 23,342 RPSRs granted under the 2011 LTISP on 2/16/23 with a measurement period ending on 12/31/25; (iii) 24,309 RPSRs granted under the 2011 LTISP on 2/14/24 with a measurement period ending on 12/31/26; and (iv) 25,628 RPSRs granted under the 2024 LTISP on 2/18/25 with a measurement period ending on 12/31/27. Read SEC document |
| February 18, 2025 Filed Feb 20, 2025 22:19 UTC | NORTHROP GRUMMAN CORP /DE/ NOC · Entity 2963 | Tax withholdingCommon Stock | 4,925 | $441.36 | $2,173,698.00 |
DisclosureSEC source: 0001628280-25-006867 · wk-form4_1740089980.xml · nonDerivative · entry 4 Warden Kathy J · CIK 0001559112 · Director · Chair, CEO and President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 216,602.4 Read SEC document |
| February 18, 2025 Filed Feb 20, 2025 22:19 UTC | NORTHROP GRUMMAN CORP /DE/ NOC · Entity 2963 | Exercise / conversionCommon Stock | 11,672 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-25-006867 · wk-form4_1740089980.xml · nonDerivative · entry 3 Warden Kathy J · CIK 0001559112 · Director · Chair, CEO and President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 221,527.4 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 18, 2025 Filed Feb 20, 2025 22:19 UTC | NORTHROP GRUMMAN CORP /DE/ NOC · Entity 2963 | Tax withholdingCommon Stock | 12,335 | $441.36 | $5,444,175.60 |
DisclosureSEC source: 0001628280-25-006867 · wk-form4_1740089980.xml · nonDerivative · entry 2 Warden Kathy J · CIK 0001559112 · Director · Chair, CEO and President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 209,855.4 Read SEC document |
| February 18, 2025 Filed Feb 20, 2025 22:19 UTC | NORTHROP GRUMMAN CORP /DE/ NOC · Entity 2963 | Exercise / conversionCommon Stock | 27,350.27 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-25-006867 · wk-form4_1740089980.xml · nonDerivative · entry 1 Warden Kathy J · CIK 0001559112 · Director · Chair, CEO and President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 222,190.4 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 31, 2024 Filed Jun 4, 2024 18:59 UTC | Merck & Co., Inc. MRK · Entity 2807 | GrantPhantom Stock · Derivative | 1,752.4295 | $125.54 | $220,000.00 |
DisclosureSEC source: 0001127602-24-017595 · form4.xml · derivative · entry 2 Warden Kathy J · CIK 0001559112 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,252.4969 Underlying: Common Stock · 1,752.4295 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F2 · derivative.exercise_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F2 · derivative.expiration_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F3 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| February 16, 2024 Filed Feb 21, 2024 22:24 UTC | NORTHROP GRUMMAN CORP /DE/ NOC · Entity 2963 | Exercise / conversionRestricted Stock Rights · Derivative | 14,776 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-24-005985 · wk-form4_1708554243.xml · derivative · entry 3 Warden Kathy J · CIK 0001559112 · Director · Chair, CEO and President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 33,587 Underlying: Common Stock · 14,776 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Right ("RSR") represents a contingent right to receive an equivalent number of shares in Issuer common stock, or, at the election of the Issuer's Compensation Committee, cash or a combination of cash and Issuer common stock. F1 · derivative.exercise_date: Each Restricted Stock Right ("RSR") represents a contingent right to receive an equivalent number of shares in Issuer common stock, or, at the election of the Issuer's Compensation Committee, cash or a combination of cash and Issuer common stock. F2 · derivative.expiration_date: Shares issued upon vesting of RSRs granted under the Long-Term Incentive Stock Plan ("LTISP") on 2/16/21 that vested on 2/16/24. Read SEC document |
| February 16, 2024 Filed Feb 21, 2024 22:24 UTC | NORTHROP GRUMMAN CORP /DE/ NOC · Entity 2963 | Tax withholdingCommon Stock | 6,664 | $450.96 | $3,005,197.44 |
DisclosureSEC source: 0001628280-24-005985 · wk-form4_1708554243.xml · nonDerivative · entry 2 Warden Kathy J · CIK 0001559112 · Director · Chair, CEO and President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 194,840.13 Read SEC document |
| February 16, 2024 Filed Feb 21, 2024 22:24 UTC | NORTHROP GRUMMAN CORP /DE/ NOC · Entity 2963 | Exercise / conversionCommon Stock | 14,776 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-24-005985 · wk-form4_1708554243.xml · nonDerivative · entry 1 Warden Kathy J · CIK 0001559112 · Director · Chair, CEO and President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 201,504.13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 14, 2024 Filed Feb 16, 2024 19:23 UTC | NORTHROP GRUMMAN CORP /DE/ NOC · Entity 2963 | Exercise / conversionRestricted Performance Stock Rights · Derivative | 45,832.05 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-24-005305 · wk-form4_1708111414.xml · derivative · entry 5 Warden Kathy J · CIK 0001559112 · Director · Chair, CEO and President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 73,212 Underlying: Common Stock · 45,832.05 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each Restricted Performance Stock Right ("RPSR") represents a contingent right to receive an equivalent number of shares of Issuer common stock, or, at the Issuer's election, cash or a combination of cash and Issuer common stock. The RPSRs vest if the applicable performance metric is satisfied for the relevant measurement period. Grants awarded pursuant to Rule 16b-3(d). F2 · derivative.exercise_date: Each Restricted Performance Stock Right ("RPSR") represents a contingent right to receive an equivalent number of shares of Issuer common stock, or, at the Issuer's election, cash or a combination of cash and Issuer common stock. The RPSRs vest if the applicable performance metric is satisfied for the relevant measurement period. Grants awarded pursuant to Rule 16b-3(d). F2 · derivative.expiration_date: Each Restricted Performance Stock Right ("RPSR") represents a contingent right to receive an equivalent number of shares of Issuer common stock, or, at the Issuer's election, cash or a combination of cash and Issuer common stock. The RPSRs vest if the applicable performance metric is satisfied for the relevant measurement period. Grants awarded pursuant to Rule 16b-3(d). Read SEC document |
| February 14, 2024 Filed Feb 16, 2024 19:23 UTC | NORTHROP GRUMMAN CORP /DE/ NOC · Entity 2963 | GrantRestricted Performance Stock Rights · Derivative | 37,636.05 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-24-005305 · wk-form4_1708111414.xml · derivative · entry 4 Warden Kathy J · CIK 0001559112 · Director · Chair, CEO and President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 119,044.05 Underlying: Common Stock · 37,636.05 shares Expires not disclosed F2 · derivative.exercise_price: Each Restricted Performance Stock Right ("RPSR") represents a contingent right to receive an equivalent number of shares of Issuer common stock, or, at the Issuer's election, cash or a combination of cash and Issuer common stock. The RPSRs vest if the applicable performance metric is satisfied for the relevant measurement period. Grants awarded pursuant to Rule 16b-3(d). F3 · shares: The RPSRs acquired include (i) 13,327.05 vested RPSRs with respect to the measurement period ended 12/31/23 acquired due to settlement of the RPSRs granted under the LTISP on 2/16/21 that resulted in settlement at 141% of the target award; and (ii) 24,309 unvested RPSRs granted under the LTISP on 2/14/24 with a measurement period ending on 12/31/26. A total of 45,832.05 shares were issued in settlement of the 2021 RPSRs with a measurement period that ended 12/31/23, and the target award amount of 32,505 RPSRs was previously reported in connection with the grant of the 2021 RPSRs. F2 · derivative.exercise_date: Each Restricted Performance Stock Right ("RPSR") represents a contingent right to receive an equivalent number of shares of Issuer common stock, or, at the Issuer's election, cash or a combination of cash and Issuer common stock. The RPSRs vest if the applicable performance metric is satisfied for the relevant measurement period. Grants awarded pursuant to Rule 16b-3(d). F2 · derivative.expiration_date: Each Restricted Performance Stock Right ("RPSR") represents a contingent right to receive an equivalent number of shares of Issuer common stock, or, at the Issuer's election, cash or a combination of cash and Issuer common stock. The RPSRs vest if the applicable performance metric is satisfied for the relevant measurement period. Grants awarded pursuant to Rule 16b-3(d). Read SEC document |
| February 14, 2024 Filed Feb 16, 2024 19:23 UTC | NORTHROP GRUMMAN CORP /DE/ NOC · Entity 2963 | GrantRestricted Stock Rights · Derivative | 11,155 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-24-005305 · wk-form4_1708111414.xml · derivative · entry 3 Warden Kathy J · CIK 0001559112 · Director · Chair, CEO and President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 48,363 Underlying: Common Stock · 11,155 shares Expires not disclosed F1 · derivative.exercise_price: Each Restricted Stock Right ("RSR") represents a contingent right to receive an equivalent number of shares in Issuer common stock, or, at the election of the Issuer's Compensation Committee, cash or a combination of cash and Issuer common stock. The RSRs were granted under the Long-Term Incentive Stock Plan ("LTISP") on 2/14/24 and will vest on 2/14/27. F1 · derivative.exercise_date: Each Restricted Stock Right ("RSR") represents a contingent right to receive an equivalent number of shares in Issuer common stock, or, at the election of the Issuer's Compensation Committee, cash or a combination of cash and Issuer common stock. The RSRs were granted under the Long-Term Incentive Stock Plan ("LTISP") on 2/14/24 and will vest on 2/14/27. F1 · derivative.expiration_date: Each Restricted Stock Right ("RSR") represents a contingent right to receive an equivalent number of shares in Issuer common stock, or, at the election of the Issuer's Compensation Committee, cash or a combination of cash and Issuer common stock. The RSRs were granted under the Long-Term Incentive Stock Plan ("LTISP") on 2/14/24 and will vest on 2/14/27. Read SEC document |
| February 14, 2024 Filed Feb 16, 2024 19:23 UTC | NORTHROP GRUMMAN CORP /DE/ NOC · Entity 2963 | Tax withholdingCommon Stock | 20,335 | $446.37 | $9,076,933.95 |
DisclosureSEC source: 0001628280-24-005305 · wk-form4_1708111414.xml · nonDerivative · entry 2 Warden Kathy J · CIK 0001559112 · Director · Chair, CEO and President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 186,728.13 Read SEC document |
| February 14, 2024 Filed Feb 16, 2024 19:23 UTC | NORTHROP GRUMMAN CORP /DE/ NOC · Entity 2963 | Exercise / conversionCommon Stock | 45,832.05 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-24-005305 · wk-form4_1708111414.xml · nonDerivative · entry 1 Warden Kathy J · CIK 0001559112 · Director · Chair, CEO and President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 207,063.13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 26, 2023 Filed May 31, 2023 19:08 UTC | Merck & Co., Inc. MRK · Entity 2807 | GrantPhantom Stock · Derivative | 1,980.7329 | $111.07 | $220,000.00 |
DisclosureSEC source: 0001127602-23-017202 · form4.xml · derivative · entry 2 Warden Kathy J · CIK 0001559112 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,228.9874 Underlying: Common Stock · 1,980.7329 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F2 · derivative.exercise_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F2 · derivative.expiration_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. Read SEC document |
| February 16, 2023 Filed Feb 21, 2023 21:56 UTC | NORTHROP GRUMMAN CORP /DE/ NOC · Entity 2963 | Exercise / conversionRestricted Performance Stock Rights · Derivative | 36,499.95 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-23-004343 · wf-form4_167701653763779.xml · derivative · entry 5 Warden Kathy J · CIK 0001559112 · Director · Chair, CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 81,408 Underlying: Common Stock · 36,499.95 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each Restricted Performance Stock Right ("RPSR") represents a contingent right to receive an equivalent number of shares of Issuer common stock, or, at the Issuer's election, cash or a combination of cash and Issuer common stock. The RPSRs vest if the applicable performance metric is satisfied for the relevant measurement period. Grants awarded pursuant to Rule 16b-3(d). F2 · derivative.exercise_date: Each Restricted Performance Stock Right ("RPSR") represents a contingent right to receive an equivalent number of shares of Issuer common stock, or, at the Issuer's election, cash or a combination of cash and Issuer common stock. The RPSRs vest if the applicable performance metric is satisfied for the relevant measurement period. Grants awarded pursuant to Rule 16b-3(d). F2 · derivative.expiration_date: Each Restricted Performance Stock Right ("RPSR") represents a contingent right to receive an equivalent number of shares of Issuer common stock, or, at the Issuer's election, cash or a combination of cash and Issuer common stock. The RPSRs vest if the applicable performance metric is satisfied for the relevant measurement period. Grants awarded pursuant to Rule 16b-3(d). Read SEC document |
| February 16, 2023 Filed Feb 21, 2023 21:56 UTC | NORTHROP GRUMMAN CORP /DE/ NOC · Entity 2963 | GrantRestricted Performance Stock Rights · Derivative | 32,804.95 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-23-004343 · wf-form4_167701653763779.xml · derivative · entry 4 Warden Kathy J · CIK 0001559112 · Director · Chair, CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 117,907.95 Underlying: Common Stock · 32,804.95 shares Expires not disclosed F2 · derivative.exercise_price: Each Restricted Performance Stock Right ("RPSR") represents a contingent right to receive an equivalent number of shares of Issuer common stock, or, at the Issuer's election, cash or a combination of cash and Issuer common stock. The RPSRs vest if the applicable performance metric is satisfied for the relevant measurement period. Grants awarded pursuant to Rule 16b-3(d). F3 · shares: The RPSRs acquired include (i) 9,462.95 vested RPSRs with respect to the measurement period ended 12/31/22 acquired due to settlement of the RPSRs granted under the 2011 Long-Term Incentive Stock Plan ("LTISP") on 2/12/20 that resulted in settlement at 135% of the target award; and (ii) 23,342 unvested RPSRs granted under the LTISP on 2/16/23 with a measurement period ending on 12/31/25. A total of 36,499.95 shares were issued in settlement of the 2020 RPSRs with a measurement period that ended 12/31/22, and the target award amount of 27,037 RPSRs was previously reported in connection with the grant of the 2020 RPSRs. F2 · derivative.exercise_date: Each Restricted Performance Stock Right ("RPSR") represents a contingent right to receive an equivalent number of shares of Issuer common stock, or, at the Issuer's election, cash or a combination of cash and Issuer common stock. The RPSRs vest if the applicable performance metric is satisfied for the relevant measurement period. Grants awarded pursuant to Rule 16b-3(d). F2 · derivative.expiration_date: Each Restricted Performance Stock Right ("RPSR") represents a contingent right to receive an equivalent number of shares of Issuer common stock, or, at the Issuer's election, cash or a combination of cash and Issuer common stock. The RPSRs vest if the applicable performance metric is satisfied for the relevant measurement period. Grants awarded pursuant to Rule 16b-3(d). Read SEC document |
| February 16, 2023 Filed Feb 21, 2023 21:56 UTC | NORTHROP GRUMMAN CORP /DE/ NOC · Entity 2963 | GrantRestricted Stock Rights · Derivative | 10,760 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-23-004343 · wf-form4_167701653763779.xml · derivative · entry 3 Warden Kathy J · CIK 0001559112 · Director · Chair, CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,208 Underlying: Common Stock · 10,760 shares Expires not disclosed F1 · derivative.exercise_price: Each Restricted Stock Right ("RSR") represents a contingent right to receive an equivalent number of shares in Issuer common stock, or, at the election of the Issuer's Compensation Committee, cash or a combination of cash and Issuer common stock. The RSRs were granted under the Long-Term Incentive Stock Plan ("LTISP") on 2/16/23 and will vest on 2/17/26. F1 · derivative.exercise_date: Each Restricted Stock Right ("RSR") represents a contingent right to receive an equivalent number of shares in Issuer common stock, or, at the election of the Issuer's Compensation Committee, cash or a combination of cash and Issuer common stock. The RSRs were granted under the Long-Term Incentive Stock Plan ("LTISP") on 2/16/23 and will vest on 2/17/26. F1 · derivative.expiration_date: Each Restricted Stock Right ("RSR") represents a contingent right to receive an equivalent number of shares in Issuer common stock, or, at the election of the Issuer's Compensation Committee, cash or a combination of cash and Issuer common stock. The RSRs were granted under the Long-Term Incentive Stock Plan ("LTISP") on 2/16/23 and will vest on 2/17/26. Read SEC document |
| February 16, 2023 Filed Feb 21, 2023 21:56 UTC | NORTHROP GRUMMAN CORP /DE/ NOC · Entity 2963 | Tax withholdingCommon Stock | 16,462 | $465.35 | $7,660,591.70 |
DisclosureSEC source: 0001628280-23-004343 · wf-form4_167701653763779.xml · nonDerivative · entry 2 Warden Kathy J · CIK 0001559112 · Director · Chair, CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 161,231.08 Read SEC document |
| February 16, 2023 Filed Feb 21, 2023 21:56 UTC | NORTHROP GRUMMAN CORP /DE/ NOC · Entity 2963 | Exercise / conversionCommon Stock | 36,499.95 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-23-004343 · wf-form4_167701653763779.xml · nonDerivative · entry 1 Warden Kathy J · CIK 0001559112 · Director · Chair, CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 177,693.08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 13, 2023 Filed Feb 15, 2023 22:25 UTC | NORTHROP GRUMMAN CORP /DE/ NOC · Entity 2963 | Exercise / conversionRestricted Stock Rights · Derivative | 11,453 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-23-003771 · wf-form4_167649991689332.xml · derivative · entry 3 Warden Kathy J · CIK 0001559112 · Director · Chair, CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,448 Underlying: Common Stock · 11,453 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Right ("RSR") represents a contingent right to receive an equivalent number of shares in Issuer common stock, or, at the election of the Issuer's Compensation Committee, cash or a combination of cash and Issuer common stock. F1 · derivative.exercise_date: Each Restricted Stock Right ("RSR") represents a contingent right to receive an equivalent number of shares in Issuer common stock, or, at the election of the Issuer's Compensation Committee, cash or a combination of cash and Issuer common stock. F2 · derivative.expiration_date: Shares issued upon vesting of RSRs granted under the Long-Term Incentive Stock Plan ("LTISP") on 2/12/20 that vested on 2/13/23. Read SEC document |
| February 13, 2023 Filed Feb 15, 2023 22:25 UTC | NORTHROP GRUMMAN CORP /DE/ NOC · Entity 2963 | Tax withholdingCommon Stock | 4,843 | $464.28 | $2,248,508.04 |
DisclosureSEC source: 0001628280-23-003771 · wf-form4_167649991689332.xml · nonDerivative · entry 2 Warden Kathy J · CIK 0001559112 · Director · Chair, CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 141,193.29 Read SEC document |
| February 13, 2023 Filed Feb 15, 2023 22:25 UTC | NORTHROP GRUMMAN CORP /DE/ NOC · Entity 2963 | Exercise / conversionCommon Stock | 11,453 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-23-003771 · wf-form4_167649991689332.xml · nonDerivative · entry 1 Warden Kathy J · CIK 0001559112 · Director · Chair, CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 146,036.29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 04, 2022 Filed Aug 8, 2022 21:00 UTC | NORTHROP GRUMMAN CORP /DE/ NOC · Entity 2963 | SaleCommon Stock | 400 | $485.73 | $194,292.00 |
DisclosureSEC source: 0001628280-22-021617 · wf-form4_165999240755936.xml · nonDerivative · entry 9 Warden Kathy J · CIK 0001559112 · Director · Chair, CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 134,583.29 F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F10 · price: Represents the weighted average sale price of $485.73 rounded to the nearest hundredth. The highest price at which the shares were sold was $485.80 and the lowest price at which the shares were sold was $485.67. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote in this Form 4. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.